147 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
ARRY Array BioPharma Inc. $11.33 $1.95B N/A
Article Searches
Biotech Stock Roundup: AMGN Resubmits Evenity BLA, Advaxis Soars, Regulatory Updates http://www.zacks.com/stock/news/311982/biotech-stock-roundup-amgn-resubmits-evenity-bla-advaxis-soars-regulatory-updates?cid=CS-ZC-FT-311982 Jul 18, 2018 - It has been a pretty ho-hum week for the biotech sector with a few regulatory updates. Amgen resubmits BLA for osteoporosis drug and Advaxis surges on positive news from FDA.
3 Things In Biotech, July 16: Array Gets An Important Update https://seekingalpha.com/article/4187583-3-things-biotech-july-16-array-gets-important-update?source=feed_all_articles Jul 16, 2018 - Array's melanoma combo gets a guideline nod. Atossa looks for a window of opportunity in breast cancer. Astellas and Pfizer score widened approval for Xtandi.
Financial & Investment Management Group Ltd Buys Omnicom Group Inc, Blackrock Credit ... http://www.gurufocus.com/news/707541/financial--investment-management-group-ltd-buys-omnicom-group-inc-blackrock-credit-allocation-income-trust-regeneron-pharmaceuticals-inc-sells-schwab-intermediateterm-us-treasury-associated-capital-group-inc-nokia-oyj Jul 13, 2018 - Financial & Investment Management Group Ltd Buys Omnicom Group Inc, Blackrock Credit Allocation Income Trust, Regeneron Pharmaceuticals Inc, Sells Schwab Intermediate-Term U.S. Treasury, Associated Capital Group Inc, Nokia Oyj, Stocks: OMC,BTZ,REGN,HBI,ARRY,IGR,AGIO,FWONK,BRK.A,GDO,FAX, release date:Jul 13, 2018
Wells Fargo Projects Sustained Growth For British Telecom Supplier Arris http://feeds.benzinga.com/~r/benzinga/~3/jt1j9bmt0QQ/wells-fargo-projects-sustained-growth-for-british-telec Jul 12, 2018 -

Wells Fargo initiated coverage of ARRIS International plc (NASDAQ: ARRS) with above-consensus estimates for 2018, 2019 and 2020.

Key FDA Events in June Investors Need to Watch Out For http://www.zacks.com/stock/news/306171/key-fda-events-in-june-investors-need-to-watch-out-for?cid=CS-ZC-FT-306171 Jun 01, 2018 - Investors in the healthcare industry are likely to keep a watch on upcoming PDUFA dates for key drugs in Jun 2018.
Core Biotech Buys #17: Positive Commentary For Gene Therapy And Our First Swap https://seekingalpha.com/article/4178491-core-biotech-buys-17-positive-commentary-gene-therapy-first-swap?source=feed_tag_etf_portfolio_strategy May 31, 2018 - FDA Commissioner Scott Gottlieb´s remarks concerning the potential of gene therapy, bode well for stocks participating in that theme.A clinical hold for CRISPR Therapeutics caused some concern but I p
Core Biotech Buys #16: Taking Advantage Of Weakness To Add To Conviction Ideas https://seekingalpha.com/article/4176184-core-biotech-buys-16-taking-advantage-weakness-add-conviction-ideas?source=feed_all_articles May 22, 2018 - Recent weakness in the biotech sector is an opportunity to add to conviction holdings.My ¨Week in Review¨ blog post appears to have the makings of a permanent feature due to positive feedback received
Lucky Seven: Bio Struggles, Achaogen Breaks Key Support https://seekingalpha.com/article/4176031-lucky-seven-bio-struggles-achaogen-breaks-key-support?source=feed_all_articles May 21, 2018 - Achaogen breaks key support.Aimmune Therapeutics is a buy.Immune Design keeps its head above water.
Lucky Seven: Exelixis Bounces Back, Global Blood Therapeutics Bleeds https://seekingalpha.com/article/4175647-lucky-seven-exelixis-bounces-back-global-blood-therapeutics-bleeds?source=feed_all_articles May 19, 2018 - Immune Design and Viking Therapeutics are added to the win column.Exelixis makes up for its lost ground and is grounded on concrete support.As predicted, shares in Global Blood Therapeutics bled late
Lucky Seven: Immune Design Takes Off, Institutions Place Bets On Viking Therapeutics https://seekingalpha.com/article/4174541-lucky-seven-immune-design-takes-institutions-place-bets-viking-therapeutics?source=feed_all_articles May 16, 2018 - Immune Design is beginning to run.Institutions place their bets on Viking Therapeutics. We will also do so, again.Array BioPharma becomes our second win.ChemoCentryx seems undervalued.

Pages: 123456...15

Page 1>

Related Companies

Name Exchange Price Mkt Cap
ENDP Endo International plc NASDAQ $8.66 $1.93B
SUPN Supernus Pharmaceuticals, Inc. NASDAQ $39.05 $1.98B
HZNP Horizon Pharma plc NASDAQ $12.33 $2.01B
CORT Corcept Therapeutics Incorporated NASDAQ $18.2 $2.06B
TBPH Theravance Biopharma, Inc. NASDAQ $33.5 $1.8B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Array BioPharma